- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07311616
A Study on the Effectiveness of Preventive Extensive Release of the Rotator Interval and Joint Capsule to Reduce Postoperative Stiffness in Arthroscopic Rotator Cuff Repair
December 16, 2025 updated by: Beijing Jishuitan Hospital
The incidence of rotator cuff injuries is high, especially among the elderly.
With the aging of the population, the number of surgical patients has increased significantly.
However, in the early stage after arthroscopic rotator cuff repair, a considerable proportion of patients are troubled by shoulder joint stiffness, which greatly affects the quality of life and satisfaction of patients after the operation.
Despite this, there is still a lack of clear evidence-based medical evidence regarding whether preventive extensive shoulder release and joint capsule release during arthroscopic rotator cuff repair can effectively prevent or alleviate postoperative shoulder stiffness.
To clarify this clinical issue, this project intends to conduct a single-blind randomized controlled trial (RCT).
Before the operation, patients will be randomly divided into two groups under blinding conditions: the experimental group will receive arthroscopic rotator cuff repair surgery along with preventive extensive shoulder joint release and joint capsule release, while the control group will only receive arthroscopic rotator cuff repair surgery.
After the operation, the investigators will conduct follow-up visits for 3 months, 6 months and 12 months for the two groups of patients, and perform magnetic resonance imaging (MRI) at the 12th month to assess the healing of the rotator cuff tendons.
ASES score, Constant-Murley score, Visual Analogue Scale (VAS) pain score and active range (ROM) assessment were conducted before the operation and at the follow-up at 3 months, 6 months and 12 months after the operation.
The occurrence of postoperative complications of the patients was counted at the last follow-up.
Through this study, the investigators expect to provide scientific and effective guidance for the prevention of postoperative adhesions of the shoulder joint.
Study Overview
Status
Not yet recruiting
Conditions
Study Type
Interventional
Enrollment (Estimated)
50
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Yiming Zhu
- Phone Number: 86-13693245245
- Email: zhu_yiming@hotmail.com
Study Locations
-
-
Beijing Municipality
-
Beijing, Beijing Municipality, China, 100000
- Beijing Jishuitan Hospital
-
Contact:
- Yiming Zhu
- Phone Number: 86-13693245245
- Email: zhu_yiming@hotmail.com
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Medium to small-sized (tear size <3 cm) full-thickness supraspinatus muscle tears
- There was no shoulder joint stiffness before the operation. The range of motion of the joint was at least 160° for passive forward flexion under ROM anesthesia, 60° for external rotation when abduction was 0°, and equal to or greater than 60° for passive internal rotation at the level of the 10th thoracic vertebra
- About to undergo ARCR
- No history of trauma
- Patient consent to participate
Exclusion Criteria:
- There was a history of previous surgery on the ipsilateral shoulder
- Other injuries or lesions of the ipsilateral shoulder (such as glenohumeral arthritis, combined acromioclavicular joint dislocation, brachial plexus injury, etc.)
- It can not be completely repaired or even repaired during operation
- Have uncontrolled epilepsy or psychological illness
- Patients who were assessed as not suitable for inclusion in the study group
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Experimental Group
The experimental group underwent arthroscopic rotator cuff repair combined with preventive extensive shoulder release and capsular release simultaneously.
|
Before rotator cuff repair, extensive release of the rotator cuff space is performed first, as well as comprehensive release of the middle glenohumeral ligament, inferior glenohumeral ligament, coracohumeral ligament, the area around the subscapularis tendon, the subacromial capsule, and the anterior and posterior inferior joint capsules.
Arthroscopic rotator cuff repair surgery
|
|
Other: Control Group
The control group only received arthroscopic rotator cuff repair surgery.
|
Arthroscopic rotator cuff repair surgery
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Shoulder Pain and Daily Functional Evaluation Measured By American Shoulder and Elbow Surgeons Score (ASES Questionnaire)
Time Frame: At baseline and at 3, 6 and 12 months after the operation.
|
This outcome measure will be assessed using the American Shoulder and Elbow Surgeons Score (ASES), a disease-specific patient-reported outcome questionnaire.
The scale consists of two key dimensions: pain (50 points, measured by Visual Analog Scale) and daily living functions (50 points, evaluating 10 activities including dressing, combing hair, and using the toilet).
The total score ranges from 0 to 100, with higher scores indicating better shoulder function and less pain.
|
At baseline and at 3, 6 and 12 months after the operation.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Shoulder Function Measured By Constant-Murley Score
Time Frame: At baseline and at 3, 6 and 12 months after the operation.
|
The Constant - Murley Score is a validated scale developed in 1986 for evaluating shoulder joint function, consisting of four assessment dimensions.
It includes pain level (15 points), daily living activities (20 points), shoulder range of motion (40 points), and muscle strength (25 points), with a total score of 0 - 100.
A higher score indicates better shoulder joint function.
The subjective parts (pain and daily living activities) are completed by subjects themselves, while the objective parts (range of motion and muscle strength) are evaluated and recorded by researchers.
|
At baseline and at 3, 6 and 12 months after the operation.
|
|
Patient-Reported Shoulder Pain Intensity Measured by Visual Analogue Scale (0-10 Scale)
Time Frame: At Basline, 1 day after the operation, and 3, 6, and 12 months after the operation
|
This outcome measure evaluates the intensity of shoulder pain in patients with supraspinatus muscle tear.
A 100mmVAS ruler is used as the measurement tool (0mm= no pain, 100mm= extreme pain) to measure the intensity of shoulder pain in participants at baseline, 1 day after operation, 3 months, 6 months and 12 months of follow-up.
Record the changes in VAS scores from baseline to each time point to reflect the intervention effect.The Visual Analogue Scale ranges from a minimum of 0 to a maximum of 10, and the higher the score, the worse the result.
|
At Basline, 1 day after the operation, and 3, 6, and 12 months after the operation
|
|
Range of Motion (ROM)
Time Frame: At baseline and at 3, 6, and 12 months after operation
|
Postural photos were taken to measure the Angle of joint movement
|
At baseline and at 3, 6, and 12 months after operation
|
|
Rate of Postoperative Complications
Time Frame: At 6 weeks, 3 months, 6 months and 12 months after the operation.
|
Inquire about the medical history to identify postoperative complications in paticipants.
|
At 6 weeks, 3 months, 6 months and 12 months after the operation.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Estimated)
December 22, 2025
Primary Completion (Estimated)
December 1, 2027
Study Completion (Estimated)
December 1, 2027
Study Registration Dates
First Submitted
November 30, 2025
First Submitted That Met QC Criteria
December 16, 2025
First Posted (Actual)
December 31, 2025
Study Record Updates
Last Update Posted (Actual)
December 31, 2025
Last Update Submitted That Met QC Criteria
December 16, 2025
Last Verified
November 1, 2025
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- MR-11-25-079098
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
IPD Plan Description
We will provide de-identified individual participant data, study protocols, statistical analysis plans, and summaries of clinical study reports.
These data include all variables analyzed in the primary and secondary outcome measures.
IPD Sharing Time Frame
The data will become available beginning 6 months after the publication of the primary study results and will remain accessible for at least 3 years.
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- SAP
- ICF
- ANALYTIC_CODE
- CSR
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Supraspinatus Tear
-
Smith & Nephew, Inc.CompletedPartial Thickness Supraspinatus Tendon Tear | Full Thickness Supraspinatus Tendon TearUnited States
-
The University of Western AustraliaArthrex, Inc.UnknownSupraspinatus TearAustralia
-
Izmir Katip Celebi UniversityEnrolling by invitation
-
La Tour HospitalRecruitingSupraspinatus TearUnited States, Switzerland, Canada
-
Dr. Soetomo General HospitalRecruitingSupraspinatus TearIndonesia
-
Fundacion para la Investigacion Biomedica del Hospital...Active, not recruiting
-
Meir Medical CenterWithdrawnPartial Supraspinatus TearIsrael
-
Assiut UniversityUnknownSupraspinatus Tear or Rupture, Not Specified as Traumatic
Clinical Trials on Prophylactic extensive shoulder release and capsular release
-
Acibadem UniversityRecruitingAdhesive Capsulitis | Frozen ShoulderTurkey (Türkiye)
-
Royal Devon and Exeter NHS Foundation TrustCompletedFrozen ShoulderUnited Kingdom
-
Bergen Surgical HospitalHaukeland University Hospital; Haraldsplass Deaconess HospitalUnknownAdhesive CapsulitisNorway
-
Akin CilTerminatedAdhesive Capsulitis of the ShoulderUnited States
-
University of LahoreCompletedCervicogenic HeadachePakistan
-
Ankara City Hospital BilkentCompletedMuscle Weakness Condition | Osteoarthritis, Hip | Hip Osteoarthritis | Fatty Degeneration | Gluteus Maximus Muscle AtrophyTurkey
-
University of OxfordWellcome Trust; National Institute for Health Research, United Kingdom; Arthritis...CompletedOsteoarthritis | Rotator Cuff Tear | Avascular Necrosis | Inflammatory Arthritis | Shoulder Dislocation | Dupuytren Contracture | Impingement Syndrome, Shoulder | Elbow Arthropathy | Trigger Digit | Shoulder Arthropathy | Upper Limb Nerve Lesion | Wrist Arthropathy | Fracture Elbow | Dislocations | Fracture, Shoulder | Arthropathy... and other conditions
-
Riphah International UniversityCompleted
-
Maasstad HospitalRecruitingCarpal Tunnel Syndrome (CTS) | Lacertus SyndromeNetherlands
-
Riphah International UniversityNot yet recruitingDizziness | Cervicogenic HeadachePakistan